InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
14
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Russell Alan J, Directeur Scientifique. Officer active across 1 company, notably Edgewise Therapeutics, Inc.. Aggregated, 27 reports have been published. Split: 0 buy · 14 sells. Total volume traded: €2.8m. History available since 23 September 2021. The latest transaction was disclosed on 12 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Russell Alan J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations27 total
5,781 shares0Common StockSEC:0001853529-26-000002:0
7,031 shares0Common StockSEC:0001853529-26-000002:1
2,273 shares@ US$43.67590.0023% mcap3.0% of flowCommon StockSEC:0001853529-26-000002:3
3,238 shares@ US$43.67750.0033% mcap4.2% of flowCommon StockSEC:0001853529-26-000002:2
390 shares@ US$44.460.0004% mcap0.5% of flowCommon StockSEC:0001853529-26-000002:4
100,000 shares@ US$0.180.6% of flowCommon StockSEC:0001853529-25-000007:0
100,000 shares@ US$0.180.6% of flowCommon StockSEC:0001853529-25-000003:0
5,781 shares0Common StockSEC:0001562180-25-005796:0
5,209 shares0Common StockSEC:0001562180-25-003660:0
200 shares@ US$0.180.0% of flowCommon StockSEC:0001562180-25-002294:0
8,015 shares@ US$0.180.0% of flowCommon StockSEC:0001562180-25-001026:0
100,000 shares@ US$0.180.5% of flowCommon StockSEC:0001562180-24-008663:0
75,000 shares@ US$0.180.3% of flowCommon StockSEC:0001562180-24-006947:0
5,208 shares0Common StockSEC:0001562180-24-003827:0
172,585 shares@ US$9.329338.4% of flowCommon StockSEC:0001562180-23-008571:0
5,208 shares0Common StockSEC:0001562180-23-003920:0
147,585 shares@ US$0.180.9% of flowCommon StockSEC:0001562180-21-007369:0
441 shares@ US$19.07080.3% of flowCommon StockSEC:0001562180-21-007134:0
16,864 shares@ US$19.940410.8% of flowCommon StockSEC:0001562180-21-007025:0
7,392 shares@ US$19.76354.7% of flowCommon StockSEC:0001562180-21-006901:0
469 shares@ US$18.02460.3% of flowCommon StockSEC:0001562180-21-006811:0
5,749 shares@ US$18.183.4% of flowCommon StockSEC:0001562180-21-006498:0
1,270 shares@ US$18.020.7% of flowCommon StockSEC:0001562180-21-006455:0
2,108 shares@ US$18.031.2% of flowCommon StockSEC:0001562180-21-006391:0
274 shares@ US$18.000.2% of flowCommon StockSEC:0001562180-21-006323:0
25 of 27 declarations
About Russell Alan J
Russell Alan J is Directeur Scientifique and Chief Scientific Officer at Edgewise Therapeutics, Inc. He has 22 filings in total, and across the sampled recent filings from 2021-09-27 to 2025-11-13, sales total EUR 2594952 and the most frequent transaction nature is Option exercise.
